Mycoplasma Bovis and NZ Livestock Insurance: What Farmers Need to Know

Mycoplasma bovis remains a significant biosecurity risk for NZ dairy farmers. Understanding your insurance coverage for mycoplasma bovis is critical risk management.

Mycoplasma bovis (M. bovis) has been a significant challenge for NZ dairy farming since its discovery in 2017. The disease causes mastitis and respiratory infections in cattle, reducing milk production and forcing culling in severe cases. Infection is notifiable under the Biosecurity Act, meaning government detection triggers testing and movement restrictions.

For dairy farmers in M. bovis-affected regions, the disease represents a real financial threat. Beyond the direct production losses from infected cows, the risk of government-mandated culling of entire herds creates exposure that can devastate farm profitability.

Insurance coverage for mycoplasma bovis varies significantly between policies and providers. Some policies provide broad notifiable disease cover that includes M. bovis compensation. Others specifically exclude certain diseases. When arranging or reviewing your dairy cattle insurance, this is not a question to leave ambiguous.

Ask your broker explicitly: "Does my policy cover financial loss from mycoplasma bovis diagnosis and treatment? Does it cover government-ordered culling if M. bovis is detected?" Get the answer in writing.

FMG's dairy insurance products specifically address M. bovis risk — they have tailored policy wordings reflecting the disease's prominence in NZ dairy. This is one area where a specialist rural insurer's deep knowledge of NZ conditions is valuable.

Beyond insurance, biosecurity practices matter. NAIT compliance, documented herd health protocols, and regular testing reduce both risk and insurance premium assessments. For dairy farmers in M. bovis-affected areas, discussion with your vet and insurer about testing and prevention protocols is worthwhile.

Coverage Types Mentioned in This Guide